SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 89 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $219,000 | -89.2% | 75,701 | -83.3% | 0.00% | -80.0% |
| Q2 2017 | $2,022,000 | +4.6% | 454,343 | +9.5% | 0.01% | 0.0% |
| Q1 2017 | $1,934,000 | +2969.8% | 415,021 | +3381.7% | 0.01% | – |
| Q3 2015 | $63,000 | -41.1% | 11,920 | -7.9% | 0.00% | – |
| Q2 2015 | $107,000 | +44.6% | 12,942 | -18.7% | 0.00% | – |
| Q1 2015 | $74,000 | +57.4% | 15,926 | +4.0% | 0.00% | – |
| Q4 2014 | $47,000 | +46.9% | 15,310 | +31.6% | 0.00% | – |
| Q3 2014 | $32,000 | -64.4% | 11,631 | -47.6% | 0.00% | – |
| Q2 2014 | $90,000 | -28.0% | 22,182 | -5.8% | 0.00% | – |
| Q1 2014 | $125,000 | +5.9% | 23,543 | +11.7% | 0.00% | – |
| Q4 2013 | $118,000 | +49.4% | 21,075 | +21.0% | 0.00% | – |
| Q3 2013 | $79,000 | +16.2% | 17,423 | +10.2% | 0.00% | – |
| Q2 2013 | $68,000 | – | 15,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
| Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
| Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
| KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
| Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
| Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
| Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
| Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |